Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROSTATA: Docetaxel + Estramustine + Hydrocortisone in Advanced Prostate Cancer
NCT00705822Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Aug 2006
- Primary completion
- Jul 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of estramustine in prostate cancer (PCa), sponsored by Sanofi. Started Aug 2006; status: terminated.
02
Drugs
estramustine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00705822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00705822.